AHI1 |
FsX1103 |
Joubert syndrome |
[241] |
Deletion of the SH3 domain |
Leukemia and lymphomas |
[242] |
MYO7A |
Missense mutation (A1628S) and truncation/deletion mutations (c.4838delA, c.5146-5148delGAG) |
Usher Syndrome or nonsyndromic deafness (DFNB2) |
[243,244] |
FRK |
R64Q |
Cervix and vulva cancer |
[245] |
YES1 |
K113Q |
Breast and colon cancer |
[245] |
ACK1 |
M393T, M409I |
Colon, Gastric adenocarcinoma |
[245,246,247,248] |
AMPH |
Q434X, K436X, Q573X, K575X |
Centronuclear Myopathy |
[249,250] |
ARHGAP10 |
Lacking the RHOGAP and SH3 domains |
Schizophrenia |
[251] |
ARHGEF9 |
G55A |
Hzperekplexia, seizures or epilepsy, developmental Delay, or intellectual disability |
[252] |
ARHGEF23 |
Missense and nonsense mutations |
Neurodevelopmental disorders |
[253] |
ARHGEF30 |
V5668A |
Breast cancer |
[101] |
A5660V |
Cardiomyopathies |
[254] |
CD2AP |
K301M |
Sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS) |
[255] |
BIN1 |
Q434X, K436X, Q573X, K575X, P593HfsX54, X594DfsX53 |
Centronuclear myopathy (CNM) |
[249,256] |
rs138047593 (K358 R (KR)) |
Alzheimer’s disease |
[257,258] |
BLK |
A71T |
Autoimmune diseases, (e.g., systemic lupus erythematosus (SLE)) |
[259] |
BTK |
Deletion of C-terminal 14 aa residues of SH3 domain |
X-linked agammaglobulinemia (XLA) |
[260,261] |
LYN |
SH3 mutations (transformative and non-transformative) |
Cancer (uterine, sarcoma, thyroid, liver, head and neck, melanoma, lung, glioma, kidney, breast, hematologic) |
[39] |
MIA |
High expression |
Melanoma development, progression and metastasis |
[74] |
MYO15A |
G2909S, G2941Vfs*94, W2931Gfs*103, R2923*, P2880Rfs*19, R2903*, R2924H, G2938R, V2940fs*3034 |
Human Deafness |
[262,263] |
NPHP1 |
2q13 |
Autosomal recessive cystic kidney disease |
[264] |
L180P |
Familial Juvenile Nephronophthisis |
[265] |
PEX13 |
Missense mutation at SH3, nonsense mutation of W234ter, temperature sensitive mutation of I326T, W313G |
Peroxisome-biogenesis disorders (PBDs) including Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease |
[266,267,268,269] |
PLC-γ1 |
Substitution mutations |
Adult T cell leukemia/lymphoma, angioimmunoblastic T-cell lymphomas, T-cell prolymphocytic leukemia, Sézary Syndrome, PLAID, autoinflammation, immune deficiency |
[270,271,272,273] |
PSTPIP1 |
D384G, G403E, G403R, R405C |
Autoinflammatory diseases (most notably in the PAPA syndrome; pyogenic sterile arthritis, pyoderma gangrenosum, and acne) and CVID (common variable immunodeficiency) |
[274,275] |
PTK6 |
L16F |
Cancer |
[276] |
RASA1 |
Missense, nonsense, frame shift, and splice site mutation |
Cancer, capillary malformation (CM) |
[277,278] |
RIMBP1 |
G1808S |
Autosomal recessive dystonia |
[279] |
SASH1 |
S587R, M595T, E617K, I586M, S587R, M595T |
DUH (dyschromatosis universalis hereditaria) and lentiginous phenotype |
[280,281] |
SH3PXD2B |
Non-synonymous coding sequence variations (G245R, E396K, G481R) |
Axenfeld–Rieger syndrome |
[282] |
BDCS3 deletion (deletion of two C-terminus SH3 domains) |
Borrone dermato-cardio-skeletal syndrome |
[283] |
SHANK1 |
R874H |
Autism spectrum disorder |
[284] |
SHANK2 |
S557N, R569H |
Autism spectrum disorder |
[285] |
SHANK3 |
Lacking parts of the SH3 domain in case of G1527A |
Autism spectrum disorder and intellectual disability (ID) |
[286] |
SPTAN1 |
D2303_L2305dup |
Epileptic encephalopathy |
[287] |
VAV1 |
L801P |
Cancer |
[288] |
STAC3 |
W > S substitution |
Native American myopathy |
[289] |
P269R, N281S, W284S, F295L, H311R, K329N |
Native American myopathy, dystrophin-deficient muscles |
[289,290,291,292] |
OBSCN |
V5668A |
Breast cancer |
[293] |
CASK |
G659D |
Severe intellectual disability (ID), microcephaly and pontine, and cerebellar hypoplasia in girls (MICPCH) |
[294] |